Quarterly Activities Report /Appendix 4C Cash Flow Statement
-2d
Significant Cardioprotection Qualities in AI-168 Studies
-2m
Appointment of Pharmaceutical Executive
-2m
24 New AI-Generated Drug Targets
-2m
-3m
Notification regarding unquoted securities - 1AI
-3m
Proposed issue of securities - 1AI
-3m
-3m
AGM Chairman Address to Shareholders
-3m
Quarterly Activities Report /Appendix 4C Cash Flow Statement
-3m